Each tablet contains standardised senna 7.5 mg with total sennosides calculated as sennoside B.
A selective neuromuscular stimulant of the colon, restoring normal rhythmic motility.
The physiological action of the natural anthrone glycosides in Senokot is virtually colon-specific. The active glycosides are protected by a natural sugar moiety which safeguards their transport to the large bowel, where bacterial action breaks the sugar-anthrone bond and releases the active fraction. Peristalsis is then stimulated via the submucosal and myenteric nerve plexuses.
Being colon-specific, Senokot does not affect the vital nutritional functions of the upper gastrointestinal tract.
Simple constipation, whether self-induced or environmental eg, neglect of the call to stool or poor sanitary conditions. Constipation in old age, especially where maintenance treatment is required. Constipation in pregnancy and the puerperium. Idiopathic slow-transit constipation. Constipation in the irritable bowel syndrome. Conservative treatment of haemorrhoids. Avoidance of straining after surgery and in cerebral and cardiovascular disease.
The correct dose is that which gives a comfortable, soft-formed motion. Adults, including Elderly and Children >12 years: 2-4 tabs. Children >6 years: 1-2 tabs.
New users should start with the lowest doses and, if necessary, increase it by ½ the initial dose each day until a comfortable formed motion is produced. If no bowel action has occurred after 3 days progressively increased dosage, a further medical examination should be considered.
Senokot is best taken as a single dose, at bedtime by adults and in the morning by children. Tablets may be swallowed whole, followed by a drink if desired.
There is no indication that dosage need be modified for the elderly.
Overdosage may occasionally cause griping. In case of gross accidental overdosage, where diarrhoea is severe, conservative measures are usually sufficient ie, generous amounts of fluid especially fruit drinks should be given.
Patients with cramps, colic, nausea, vomiting or other symptoms of appendicitis or any undiagnosed abdominal pain.
Use in lactation: Clinical studies have shown that breastfed infants of mothers taking Senokot did not show any side effects to the drug.
Use in lactation: Clinical studies have shown that breastfed infants of mothers taking Senokot did not show any side effects to the drug.
Senokot has no known effects on diagnostic laboratory tests.
Keep in closed, airtight containers. Store dry below 30°C.
A06AB06 - senna glycosides ; Belongs to the class of contact laxatives.
Sign Out
